Predicted to enable neuropeptide hormone activity. Involved in several processes, including cellular response to sodium phosphate; neuropeptide signaling pathway; and positive regulation of vascular associated smooth muscle cell apoptotic process. Located in extracellular space. Is active in neuronal dense core vesicle. Biomarker of chronic kidney disease. Orthologous to human GRP (gastrin releasing peptide); INTERACTS WITH 3,7-dihydropurine-6-thione; 6-propyl-2-thiouracil; adenine.
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRP mRNA
[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GRP gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of GRP gene
marimastat inhibits the reaction [GRP protein results in increased cleavage of and results in increased secretion of AREG protein] and marimastat inhibits the reaction [GRP protein results in increased cleavage of and results in increased secretion of TGFA protein]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRP mRNA
Morphofunctional characteristics of the gastrin-releasing peptide-synthesizing system of the hypothalamus in normal conditions and in experimental diabetes in rats.
Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions.
Gamma-aminobutyrate, gastrin releasing peptide, serotonin, somatostatin, and vasopressin: ultrastructural immunocytochemical localization in presynaptic axons in the suprachiasmatic nucleus.